Recon: Wegovy use up 50% among US teens; Hims to acquire UK-based telehealth firm Zava
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.In Focus: US
- Wegovy use among US teens up 50% as obesity crisis worsens (Reuters)
- New HHS document details deep NIH cuts as part of Trump budget request (STAT) (The Hill) (MedtechDive)
- HHS has a new national health IT coordinator (STAT)
- Q&A: Sandoz CEO Richard Saynor on generic GLP-1s, Trump's industry impact, and Mark Cuban's company (STAT)
- FDA's 2026 budget plan seeks to shrink overall funds, but increase user fees (Endpoints)
- DOGE set today as their last day at FDA. Instead, they're continuing to get full pay and don't work (Endpoints)
- The MAHA Report’s Errors Are Just the Start of Its Problems (Bloomberg)
- Hims to acquire UK-based startup Zava as it expands international presence (Reuters)
- US ‘Most Favored Nations’ Drug Pricing Policy Will Jeopardize Innovation In Europe (Pink Sheet)
- Australia Looks To Modernize Human Tissue Laws, Improving Access For Researchers (Pink Sheet)
- China NMPA Lays Out Regulatory Priorities At DIA (Pink Sheet)
- China Criticizes EU’s Planned Curb on Medical Device Procurement (Bloomberg)
- The US slashed HIV/AIDS funding. Here is how countries that relied on it might adapt (STAT)
- Novartis' Pluvicto shown to slow prostate cancer in earlier setting (Reuters)
- BioNTech presents impressive early data for PD-L1xVEGF in mesothelioma (Endpoints)
- At ASCO, cell therapies for deadly form of brain cancer make early strides (Endpoints)
- Vera redraws the terms of up to $500M credit facility; Trevi aims to raise $100M (Endpoints)
- Lyra’s stock soars on Phase 3 success for chronic rhinosinusitis treatment (Endpoints)
- Regeneron makes $80M obesity deal with Hansoh (Endpoints)
- 23andMe founder aims to restart auction with major corporate backing (Reuters)
- MAHA kids’ health report misinforms about tonsillectomies and ear tubes (STAT)
- Canid raises $10M to manage vaccines for pediatricians (Endpoints)
- Nvidia’s David Niewolny on the future of AI in medical devices (MedTech Dive)
- Beta Bionics CEO, CFO on how to take a company public (MedTech Dive)
- First AI Breast Cancer Prediction Platform Receives FDA Authorization (MedTech Insight)
- FDA Abandons Its Defense of the LDT Rule, But is It Signaling an Increase in RUO Scrutiny? (FDA Law Blog)
- FDA gives TurtleTree’s ingredient the green light (Food Business News)
- Snacks remain a weak spot for Campbell’s (Food Business News)
- Report: Mars removes titanium dioxide from Skittles (Food Business News)
- Funding Food Safety Training Is a Public Health Imperative (Food Safety)
- Ingredient up to 13,000 times sweeter than sugar lurks in vapes popular with teens, study shows (STAT)
- Pyx Health buys FarmboxRx to reach more Medicaid and Medicare members (Endpoints)
- Final Curtain For LDTs? FDA Will Not Appeal District Court Decision To Vacate Final Rule (MedTech Insight)
- US FDA Cell-Gene Therapy Head Says Agency Has Revived Stalled Programs (Pink Sheet)
A story’s inclusion in Regulatory Recon does not imply endorsement by Regulatory Focus or RAPS.
